The antimicrobial combination was additive against P. multocida (FIC=1) and indifferent against O. rhinotracheale (FIC=2).
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The antimicrobial activities of cefquinome and tilmicosin were determined in vitro against P. multocida and O. rhinotracheale of poultry origin by serial broth macrodilution.
📊
Key Findings & Data:The minimum inhibitory concentration (MIC) for cefquinome was 1.562 µg/ml and for tilmicosin was 0.78 µg/ml for both microorganisms.
💡
Conclusion & Impact:The antimicrobial combination was additive against P. multocida (FIC=1) and indifferent against O. rhinotracheale (FIC=2).
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
The antimicrobial activities of cefquinome and tilmicosin were determined in vitro against P. multocida and O. rhinotracheale of poultry origin by serial broth macrodilution. Both antibiotics exhibited good in vitro antibacterial activity against the strains tested. The minimum inhibitory concentration (MIC) for cefquinome was 1.562 µg/ml and for tilmicosin was 0.78 µg/ml for both microorganisms. To investigate the effects of a combination of cefquinome and tilmicosin, the fractional inhibitory concentration (FIC) index was determined by checkerboard assay. The antimicrobial combination was additive against P. multocida (FIC=1) and indifferent against O. rhinotracheale (FIC=2).
🔖
Cite This Article
AK, S., KELEŞ, O., BAKIREL, T. (2022). İn vitro antibacterial activities of tilmicosin and cefquinomme alone or in combination againt certain poultry pathogens. Turkish Journal of Veterinary and Animal Sciences, Cilt: 25 - Sayı: 4, 577–580. https://ajindex.com/articles/615698
Arda, M. ve ark: Kanatlı Hayvan Hastalıkları. Medisan yayın serisi,1990,No: 14, 86-89
McKay, S.G., Morck, D.W., Merrill, J.K., Olson, M.E., Chan, S.C., Pap, K.: Use of tilmicosin for treatment of pasteurellosis in rabbits. AJVR, 1996; 57, 8, 1180-1184
Kirst, H.A., Ose, E.E., Toth, J.E., Willard, K.E., Debone, M., FeltyDuckworth, A.M., Pekarek, R.S.: In vitro and in vivo evaluations of C-20- and C-23- modified derivates of tylosin against veterinary pathogens. The Journal of Antibiotics, 1988; 41, 7, 938-948
Ose, E. E.: In vitro antibacterial properties of EL-870, a new semisynthetic macrolide antibiotic. The Journal of Antibiotics,1987; 40, 2, 190-194
Ose, E.E., Tonkinson, L.V.: Single-dose treatmant of neonatal calf pneumonia with the new macrolide antibiotic tilmicosin. The Veterinary Record, 1988; 1, 123, 367-369
Kaya, S.: Kemoterapötikler. In: S.KAYA, İ.PİRİNÇCİ, A.BİLGİLİ, Veteriner UygulamalI Farmakoloji., cilt 2, s. 283-398. Medisan YayIn serisi No: 28, 1997; ANKARA 7. Kayaalp, O.: Rasyonel Tedavi Yönünden Tibbi Farmakoloji. 1.cilt, 7.nci baskI, Feryal matbaacılık,1994
Şanlı, Y.: Veteriner Klinik Farmakoloji ve ilaçla sağaltım ilkeleri. Medisan Yayınevi, 1999, Ankara
Barker, S., Kappel, L.C., Short, C.R.: Tissue distrubution and clearance of cefquinome in the bovine. Proceedings XVIII World Buiatric Congress, Bologna;1994
Limbert, M., Isert, D., Klesel, N., Markus, A., Seeger, K., Seibert, G., Schr›nner, E.: Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome. a new broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy. 1991; 35, 1, 14-19
Devriese, L.A., Hommez, J., Vandamme, P., Kersters, K., Haesebrouck F.: In vitro antibiotic sensitivity of Ornithobacterium rhinotracheale strains from poultry and wild birds. Veterinary Record, 1995; 21, 435-436
Empel, P. Van., Bosch, H. Van. Den., Loeffen, P.: Identification and serotyping of O. rhinotracheale. J. Clin. Microbiol., 1997; 35: 2, 418-421
Isenberg, H.D.: Clinical Microbiology Procedures Handbook. Vol. 1, American Society for Microbiology 1325 Massachusetts,1992
Hafez, H.M.: Current status of the laboratory diagnosis of Ornithobacterium rhinotracheale ‘ORT’ in poultry. Berl. Münch. Tierarztl. Wschr., 1998; 111,143-145
National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing; Eighth informational supplement. NCCLS document M 100-S7, vol. 17